CLASSIFICATION OF BREAST CANCER PATIENTS USING A COMBINATION OF CLINICAL CRITERIA AND INFORMATIVE GENESETS
Patent №
US 8,019,552
Granted
2011-09-13
Filed 2007
Owner
NETHERLANDS CANCER INSTITUTE, THE
+3 more
Lab
—
AI components
1
vision
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
10591800
The present invention provides prognostic methods for conditions such as cancer, for example, breast cancer, comprising classifying an individual by a plurality of phenotypic, genotypic or clinical characteristics of the condition into a plurality of patient subsets, and analyzing the pattern of expression of prognosis-informative genes identified for that subset in a sample from the individual. The present invention also provides methods for constructing such patient subsets and of identifying prognosis-informative genesets for such subsets. The invention further provides methods of assigning a therapeutic regimen to an individual, microarrays useful for performing prognosis, kits comprising these microarrays, and computer systems and programs for implementing the methods of the invention.
AI classification
Ownership
NETHERLANDS CANCER INSTITUTE, THE
assignment · 195670154
ROSETTA INPHARMATICS LLC
assignment · 195780606
MERCK & CO., INC.
assignment · 240900980
MERCK SHARP & DOHME CORP.
namechg · 241180558
Assignors
VAN'T VEER, LAURA J.
On an employer assignment, the assignors are typically the inventors.